» Articles » PMID: 3055961

Is Henoch-Schönlein Purpura the Systemic Form of IgA Nephropathy?

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 1988 Nov 1
PMID 3055961
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Despite different clinical features, IgA nephropathy (IgAN) and Henoch-Schönlein purpura (HSP) are indistinguishable by histopathology, leading to the suggestion that HSP is a systemic form of IgAN. This review compares and contrasts the clinical, pathologic, and experimental similarities and differences of these two disorders. Many patients with HSP have minimal extrarenal disease, while up to 30% of patients with IgAN will subsequently have systemic symptoms. Although patients with HSP are usually much younger than those with IgAN, the age distributions often overlap. Both may have recurrent macroscopic hematuria associated with pharyngitis, a similar risk of developing renal insufficiency, and recurrent disease after kidney transplantation. Although the pattern of IgA subclass and complement deposition are similar, monocytic and T lymphocytic infiltrates have been observed only in HSP. Dermal blood vessels of many patients with IgAN have IgA immunofluorescence similar to that in HSP, supporting a systemic process in IgAN. Although the pathogenesis is not clearly understood for either disease, investigations of potential disease mechanisms have revealed striking similarities. These include an up-regulated in vitro IgA immune response, circulating IgA-containing immune complexes and autoantibodies, and decreased Fc receptor-mediated immune clearance. Finally, immunogenetic studies suggest that patients with both conditions inherit a predisposition for disease.

Citing Articles

The efficacy of rituximab in the treatment of IgA vasculitis nephritis.

Xiong Y, Cuevas S, Xu G, Zou H Clin Exp Med. 2024; 24(1):213.

PMID: 39249581 PMC: 11383840. DOI: 10.1007/s10238-024-01461-6.


O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.

Novak J, King R, Yother J, Renfrow M, Green T Glycobiology. 2024; 34(11).

PMID: 39095059 PMC: 11442006. DOI: 10.1093/glycob/cwae060.


IgA Vasculitis Followed by IgA Nephropathy Without an Identifiable Trigger: The Same Disease or a Spectrum of Related Conditions?.

Lapides R, Crespo-Quezada J, Thomas T, Carmona Pires F, Chera G Cureus. 2023; 15(9):e45639.

PMID: 37868543 PMC: 10589066. DOI: 10.7759/cureus.45639.


A narrative review of potential drug treatments for nephritis in children with IgA vasculitis (HSP).

Williams C, Lamond M, Marro J, Chetwynd A, Oni L Clin Rheumatol. 2023; 42(12):3189-3200.

PMID: 37755547 PMC: 10640478. DOI: 10.1007/s10067-023-06781-8.


Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?.

Batista-Liz J, Calvo-Rio V, Sebastian Mora-Gil M, Sevilla-Perez B, Marquez A, Leonardo M Int J Mol Sci. 2023; 24(17).

PMID: 37685869 PMC: 10488110. DOI: 10.3390/ijms241713063.